Noyan, H. Et Al. 2021. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings. Schizophrenia Research , vol.229 , 27-37.

Noyan, H., ERDAĞ, E., TÜZÜN, E., YAYLIM, İ., KÜÇÜKHÜSEYİN, Ö., HAKAN, M. T., ... Gülöksüz, S.(2021). Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings. Schizophrenia Research , vol.229, 27-37.

Noyan, Handan Et Al. "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings," Schizophrenia Research , vol.229, 27-37, 2021

Noyan, Handan Et Al. "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings." Schizophrenia Research , vol.229, pp.27-37, 2021

Noyan, H. Et Al. (2021) . "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings." Schizophrenia Research , vol.229, pp.27-37.

@article{article, author={Handan Noyan Et Al. }, title={Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings}, journal={Schizophrenia Research}, year=2021, pages={27-37} }